Eugenio Galli

972 total citations
43 papers, 280 citations indexed

About

Eugenio Galli is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Eugenio Galli has authored 43 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Hematology and 8 papers in Surgery. Recurrent topics in Eugenio Galli's work include CAR-T cell therapy research (14 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Eugenio Galli is often cited by papers focused on CAR-T cell therapy research (14 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Eugenio Galli collaborates with scholars based in Italy, France and United States. Eugenio Galli's co-authors include Patrizia Chiusolo, Simona Sica, Stefan Hohaus, Federica Sorà, Sophie Caillat‐Zucman, Idanna Innocenti, Sylvie Chevret, Roberta Di Blasi, Francesco Autore and Vincent Allain and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and European Heart Journal.

In The Last Decade

Eugenio Galli

33 papers receiving 274 citations

Peers

Eugenio Galli
Noa G. Holtzman United States
Alessandro Crotta United States
Minh Tran United States
Sami Ibrahimi United States
Agrima Mian United States
Christine L. Phillips United States
LaQuisa Hill United States
Eugenio Galli
Citations per year, relative to Eugenio Galli Eugenio Galli (= 1×) peers David M. Cordas dos Santos

Countries citing papers authored by Eugenio Galli

Since Specialization
Citations

This map shows the geographic impact of Eugenio Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenio Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenio Galli more than expected).

Fields of papers citing papers by Eugenio Galli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenio Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenio Galli. The network helps show where Eugenio Galli may publish in the future.

Co-authorship network of co-authors of Eugenio Galli

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenio Galli. A scholar is included among the top collaborators of Eugenio Galli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenio Galli. Eugenio Galli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galli, Eugenio, Roberta Di Blasi, Alice Di Rocco, et al.. (2025). Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study. Blood Advances. 9(21). 5501–5509.
2.
Camilli, Massimiliano, Lucia Leccisotti, Eugenio Galli, et al.. (2025). Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance. European Heart Journal. 47(9). 1114–1117.
3.
Galli, Eugenio, Elisabetta Metafuni, Carlo Gandi, et al.. (2024). Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir‐exposed CMV‐free population receiving PTCy. European Journal Of Haematology. 112(4). 577–584. 1 indexed citations
4.
Galli, Eugenio, Elena Maiolo, Federica Sorà, et al.. (2024). Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR). International Journal of Molecular Sciences. 25(5). 2673–2673. 2 indexed citations
5.
Galli, Eugenio, Silvia Bellesi, Stefan Hohaus, et al.. (2024). FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells. Mediterranean Journal of Hematology and Infectious Diseases. 16(1). e2024029–e2024029. 2 indexed citations
6.
Raiola, Anna Maria, Carmen Di Grazia, Alida Dominietto, et al.. (2024). Haploidentical bone marrow transplantation for AML in remission after TBF conditioning: a long-term follow-up. Blood Advances. 8(8). 1964–1967. 1 indexed citations
8.
Galli, Eugenio, Silvia Bellesi, Elisabetta Metafuni, et al.. (2023). Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management. European Journal Of Haematology. 112(2). 184–196. 12 indexed citations
10.
Galli, Eugenio, Silvia Bellesi, Elena Maiolo, et al.. (2023). The CD4/CD8 ratio of infused CD19‐CAR‐T is a prognostic factor for efficacy and toxicity. British Journal of Haematology. 203(4). 564–570. 26 indexed citations
12.
Galli, Eugenio, Federica Sorà, Stefan Hohaus, et al.. (2022). Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells. British Journal of Haematology. 201(1). 86–94. 29 indexed citations
13.
Galli, Eugenio, Elisabetta Metafuni, Sabrina Giammarco, et al.. (2022). Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. Bone Marrow Transplantation. 57(4). 532–537. 8 indexed citations
14.
Galli, Eugenio, Federica Sorà, Sabrina Giammarco, et al.. (2022). Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia. Supportive Care in Cancer. 30(6). 4953–4959. 5 indexed citations
15.
Autore, Francesco, et al.. (2021). Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review. Journal of Clinical Medicine. 10(21). 5104–5104. 6 indexed citations
16.
Chiusolo, Patrizia, Francesco Autore, Sabrina Giammarco, et al.. (2021). IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?. Mediterranean Journal of Hematology and Infectious Diseases. 13(1). e2021062–e2021062. 2 indexed citations
17.
Galli, Eugenio, Annarosa Cuccaro, Elena Maiolo, et al.. (2020). Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma. Hematological Oncology. 38(2). 153–161. 7 indexed citations
18.
Galli, Eugenio, Vincent Allain, Roberta Di Blasi, et al.. (2020). G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma. Bone Marrow Transplantation. 55(12). 2347–2349. 42 indexed citations
19.
Galli, Eugenio, Francesco D’Alò, Annarosa Cuccaro, et al.. (2020). Burkitt lymphoma as fourth neoplasia in a patient affected by Cowden Syndrome with a novel PTEN germline pathogenic variant. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020034–e2020034. 3 indexed citations
20.
Leòn, Maurizio Ponz de, et al.. (1987). Fecal neutral steroids in normal conditions and in patients with polyps or cancer of the large bowel.. PubMed. 47(1). 305–10. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026